By proceeding, you agree to our Terms of Use and Privacy Policy.
Paras Biopharmaceuticals Finland Oy Paras Finland ( Europe) is a fast growing biopharmaceutical technology development company which has successfully developed the proprietary Diabrid Platform Technology for the high level expression of biosimilars a
13-14 October 2022
Industry, together with professionals and scientists are finding a way to map out some clearer directions and expectations about what is needed to improve the biopharmaceuticals processing systems.
Event Ended
Hybrid
Paid
Berlin